Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000145020 | SCV000519890 | benign | not specified | 2016-04-25 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000462246 | SCV000559477 | benign | Hereditary spastic paraplegia 47 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002312629 | SCV000847006 | benign | Inborn genetic diseases | 2016-03-19 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome Diagnostics Laboratory, |
RCV001847776 | SCV002105543 | benign | Hereditary spastic paraplegia | 2021-11-09 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000462246 | SCV004050689 | benign | Hereditary spastic paraplegia 47 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004713367 | SCV005280424 | benign | not provided | criteria provided, single submitter | not provided | ||
Genetic Services Laboratory, |
RCV000145020 | SCV000192057 | likely benign | not specified | no assertion criteria provided | clinical testing |